Drug Database · Clinicians

Chlorpheniramine + Phenylephrine

Brands (3) Coldeze Infant Drops, Disutap, PenchlorShow all

This entry appears to be Chlorphenamine + Phenylephrine registered under a variant spelling.

See the main Chlorphenamine + Phenylephrine monograph (kidney dosing, prescribing information, all brands) →

US brand (reference label): PHENAGIL; not a Philippine-registered brand.

Decongestant/Antihistamine; Nasal decongestant / antihistamine PH FDA category
Fixed-dose combination.

Rx · Prescription drugOTC · Over-the-counter5 PH products
Dispensing: Over-the-counter (OTC) · Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 69fd13a1-2b76-8574-e053-2a91aa0a27e7, version date September 2, 2026 (PHENAGIL · Gil Pharmaceutical Corp). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • runny nose
  • sneezing
  • itchy, watery eyes
  • nasal congestion
  • itching of the nose or throat
  • sinus congestion and pressure
US FDA label
Full indications and usage US FDA label

Uses Uses temporarily relieves these symptoms due to hay fever (allergic rhinitis) or other upper respiratory allergies: • runny nose • sneezing • itchy, watery eyes • nasal congestion • itching of the nose or throat • sinus congestion and pressure

Dosing: Adult

Dosage and administration (US label) US FDA label

Directions Adults and Children12 years of age and over: take 1 tablet every 4-6 hours. Do not exceed 6 tablets in 24 hours Children 6 to under 12 years of age: 1/2 tablet every 4-6 hours, not to exceed 3 tablets in a 24 our period Children under 6 years of age: Consult a physician.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Per ml syrup: 1 mg/800 mcg
  • Syrup: 5 mg/1 mg per 5 mL
  • Per ml: 1 mg/0.8 mg

Registered products in the Philippines

5 products registered with the Food and Drug Administration (FDA) Philippines list Chlorpheniramine + Phenylephrine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products5
Philippine FDA-registered products for Chlorpheniramine + Phenylephrine
Package insert
Coldeze Infant DropsPhenylephrine Hydrochloride + Chlorpheniramine Maleate
1 mg/800 mcg per mL Syrup (Oral Drops)Amber bottle x 10 mL (Box of 1's)
Rx
Lloyd Laboratories, Inc.Philippines
—
DR-XY40186 (For Export Only)
Oct 13, 2031
DisutapPhenylephrine Hydrochloride + Chlorpheniramine Maleate
5 mg/1 mg per 5 mL Syrup (Orange Flavor)PET Amber Bottle x 120 mL (Box of 1's)
OTC
Opal Laboratories (Pvt.) LimitedPakistan
Accesspoint International Trading
DRP-17094
Sep 30, 2030
NonePhenylephrine Hydrochloride + Chlorpheniramine Maleate
5 mg/1 mg per 5 mL Syrup (Orange Flavor)PET Amber Bottle x 120 mL (Box of 1's)
OTC
Opal Laboratories (Pvt.) LimitedPakistan
Reta DrugImporter: Accesspoint International Trading Inc.
DRP-17094-01
Sep 30, 2030
PenchlorPhenylephrine hydrochloride + Chlorpheniramine maleate
1 mg/ 800 mcg per mL Syrup (Oral Drops)Amber Glass Bottle x 15 mL (Box of 1's)
Rx
Lloyd Laboratories, Inc.Philippines
Altomed Pharmaceuticals, Inc.Trader: Vitalink Health Products, Inc.
DRP-8341
Nov 23, 2030
(no brand name)Phenylephrine Hydrochloride + Chlorpheniramine Maleate
1mg/0.8mg per mL (Oral Drops)Amber Glass Bottle with Aluminum Pilfer-Proof Cap x 10 mL (Box of 1's)
OTC
Am-Europharma CorporationPhilippines
Trader: Ritemed Phils., Inc.
DRP-11767
Apr 27, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes
  • trouble urinating due to an enlarged prostate gland
  • a breathing problem such as emphysema or chronic bronchitis
  • glaucoma Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers When using this product
  • do not exceed recommended dose
  • excitability may occur, especially in children
  • drowsiness may occur
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • avoid alcoholic drinks
  • be careful when driving a motor vehicle or operating machinery Stop use and ask a doctor if
  • nervousness, dizziness, or sleeplessness occurs
  • symptoms do not improve within 7 days or occur with a fever. If pregnant or breast-feeding, ask a health professional before use. Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. PHENAGIL · Gil Pharmaceutical Corp [US FDA-approved label, version 9, September 2, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=69fd13a1-2b76-8574-e053-2a91aa0a27e7
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .